Live Feeds

Source map — Novartis to License Drug From China’s Abogen in Up to $7.8 Billion Deal

Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.

SourceTypeTrust
WSJ news 60%
Reuters news 60%
CNBC news 60%
Bloomberg.com news 60%
fiercebiotech.com news 60%
axios.com news 60%
www.europesays.com news 50%
www.marketscreener.com news 50%
globalpolitics.info news 50%
for.you.com news 50%
chinaarticles.substack.com news 50%
patientdaily.com news 50%
www.pharmawire.org news 50%
www.iam-media.com news 50%
www.vcbeathealth.com news 50%
www.thepharmaletter.com news 50%
public.com news 50%
biotochina.org news 50%
thenationtimes.com news 50%
www.yeasenbio.com news 50%
www.dimabio.com news 50%
www.decibio.com news 50%
de.wikipedia.org news 50%
portals.novartis.com news 50%
medicaldialogues.in news 50%
en.wikipedia.org news 50%
novartis.wd3.myworkdayjobs.com news 50%
finance.yahoo.com news 50%
pap.novartis.com news 50%
www.marketbeat.com news 50%
www.biobucks.co news 50%
www.cnbc.com news 50%
biopharmaapac.com news 50%
biotechmorning.com news 50%
theedgemalaysia.com news 50%
www.biospace.com news 50%
www.thewirechina.com news 50%
www.gdnonline.com news 50%
www.novartis.com news 50%
www.biospectrumasia.com news 50%
capitaldigest.com news 50%